CERo Therapeutics
(OTC) CERO
CERo Therapeutics Financials at a Glance
Market Cap
$728,000
Revenue (TTM)
$1.16M
Net Income (TTM)
$14.14M
EPS (TTM)
$-97.07
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.03
Volume
211,594
Open
$0.04
Price
$0.03
Volume
211,594
Open
$0.04
Previous Close
$0.03
Daily Range
$0.03 - $0.04
52-Week Range
$0.03 - $28.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.03
Volume
211,594
Open
$0.04
Previous Close
$0.03
Daily Range
$0.03 - $0.04
52-Week Range
$0.03 - $28.40
CERO News
CERO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CERo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Christopher B. Ehrlich, MBA
Website
www.cero.bioHeadquarters
South San Francisco, CA 94080, US
CERO Financials
Key Financial Metrics (TTM)
Gross Margin
-20%
Operating Margin
-13%
Net Income Margin
-12%
Return on Equity
0%
Return on Capital
3%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$728.00K
Shares Outstanding
21.10M
Volume
211.59K
Short Interest
0.00%
Avg. Volume
531.39K
Financials (TTM)
Gross Profit
$1.16M
Operating Income
$15.30M
EBITDA
$6.57M
Operating Cash Flow
$5.79M
Capital Expenditure
$0.00
Free Cash Flow
$5.79M
Cash & ST Invst.
$3.33M
Total Debt
$1.58M
CERo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$272.77K
+8.3%
Gross Margin
0.00%
N/A
Market Cap
$728.00K
N/A
Market Cap/Employee
$91.00K
N/A
Employees
8
N/A
Net Income
$4.86M
-14.9%
EBITDA
$4.09M
+7.1%
Quarterly Fundamentals
Net Cash
$1.09M
-30.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$931.02K
-9.9%
Return on Assets
-3.61%
N/A
Return on Invested Capital
3.35%
N/A
Free Cash Flow
$3.21M
-143.1%
Operating Cash Flow
$3.21M
+14.5%